Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants

Understanding heart failure with preserved ejection fraction: where are we today?

(2016) L. van Heerebeek et al.   Netherlands Heart Journal

Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin

(2015) M. R. Zile et al.   CIRCULATION

Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91 360 patients admitted with index myocardial infarction between 1998 and 2010

(2015) Liyew Desta et al.   EUROPEAN JOURNAL OF HEART FAILURE

New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study

(2015) Erwan Donal et al.   EUROPEAN JOURNAL OF HEART FAILURE

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study

(2014) Erwan Donal et al.   Archives of Cardiovascular Diseases

Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction

(2014) Lars H. Lund et al.   EUROPEAN JOURNAL OF HEART FAILURE

Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure

(2014) Johan Löfsjögård et al.   Journal of Cardiovascular Medicine

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of Salt-Inducible Kinase 2 (SIK2) Prevents the Development of Cardiac Hypertrophy in Response to Chronic High-Salt Intake

(2014) Sergej Popov et al.   PLoS One

Developing Therapies for Heart Failure With Preserved Ejection Fraction

(2014) Javed Butler et al.   JACC-Heart Failure

Heart Disease and Stroke Statistics—2014 Update

(2013) Alan S. Go et al.   CIRCULATION

Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model

(2013) Nazha Hamdani et al.   Circulation-Heart Failure

Forecasting the Impact of Heart Failure in the United States

(2013) Paul A. Heidenreich et al.   Circulation-Heart Failure

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

(2013) Walter J. Paulus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Lipopolysaccharide Administration on the Number, Phenotype and Content of Nuclear Molecules in Blood Microparticles of Normal Human Subjects

(2013) A. Soop et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction

(2012) Benjamin A. Steinberg et al.   CIRCULATION

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology

(2012) Martin Ugander et al.   EUROPEAN HEART JOURNAL

Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction

(2012) Lars H. Lund et al.   EUROPEAN HEART JOURNAL

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

(2012) et al.   EUROPEAN JOURNAL OF HEART FAILURE

What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?

(2012) Ross T. Campbell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction

(2012) Margareta Blombäck et al.   THROMBOSIS AND HAEMOSTASIS

Platelet-derived microparticles during and after acute coronary syndrome

(2012) Fariborz Mobarrez et al.   THROMBOSIS AND HAEMOSTASIS

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction

(2011) Inder S. Anand et al.   Circulation-Heart Failure

Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance

(2011) Nathan Mewton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study

(2011) Fariborz Mobarrez et al.   THROMBOSIS RESEARCH

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography

(2009) S. F. Nagueh et al.   European Journal of Echocardiography

Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction

(2009) Erwan Donal et al.   EUROPEAN JOURNAL OF HEART FAILURE

Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy

(2008) I. Garcia-Bolao et al.   EUROPEAN HEART JOURNAL

BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction

(2008) Jasmine Grewal et al.   EUROPEAN JOURNAL OF HEART FAILURE